scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0006-8993(97)00491-5 |
P698 | PubMed publication ID | 9262181 |
P2093 | author name string | Nagata K | |
Song JH | |||
Huang CS | |||
Narahashi T | |||
Yeh JZ | |||
Twombly D | |||
P2860 | cites work | Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches | Q22337395 |
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes | Q34306269 | ||
Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. | Q35596908 | ||
Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices | Q36712664 | ||
G(o) transduces GABAB-receptor modulation of N-type calcium channels in cultured dorsal root ganglion neurons | Q36762829 | ||
The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death | Q37585239 | ||
Glutamate and the pathophysiology of hypoxic--ischemic brain damage | Q38161694 | ||
Augmentation of calcium channel currents in response to G protein activation by GTP gamma S in chick sensory neurons. | Q39482564 | ||
Modulation of ion-channel function by G-protein-coupled receptors | Q40397855 | ||
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis | Q40925698 | ||
Facilitation of Ca2+ current in excitable cells | Q41095974 | ||
Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity | Q41676626 | ||
Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action | Q42154486 | ||
Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat. | Q43696440 | ||
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre | Q43795777 | ||
Fast, local signal transduction between the mu opioid receptor and Ca2+ channels | Q44333014 | ||
mu-Opioid receptor-mediated reduction of neuronal calcium current occurs via a G(o)-type GTP-binding protein | Q44338763 | ||
The possible involvement of tetrodotoxin-sensitive ion channels in ischemic neuronal damage in the rat hippocampus | Q44762521 | ||
Cerebral cation shifts in hypoxic-ischemic brain damage are prevented by the sodium channel blocker tetrodotoxin | Q44940184 | ||
Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells | Q45368638 | ||
In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate | Q48273967 | ||
Pharmacologically distinct glutamate receptors on cerebellar granule cells | Q48333702 | ||
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo | Q48396095 | ||
Norepinephrine inhibits calcium currents and EPSPs via a G-protein-coupled mechanism in olfactory bulb neurons | Q48425912 | ||
Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia | Q48468018 | ||
Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death | Q48647769 | ||
Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsy | Q48690472 | ||
The effect of blocking sodium influx on anoxic damage in the rat hippocampal slice. | Q51760522 | ||
Ca2+ channel currents in rat sensory neurones: interaction between guanine nucleotides, cyclic AMP and Ca2+ channel ligands | Q68252404 | ||
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II | Q71177245 | ||
Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission | Q71526060 | ||
Pharmacological types of calcium channels and their modulation by baclofen in cerebellar granules | Q71689226 | ||
Substance P and somatostatin inhibit calcium channels in rat sympathetic neurons via different G protein pathwavs | Q72068927 | ||
The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1 | Q72252654 | ||
Voltage dependence of G-protein-mediated inhibition of high-voltage-activated calcium channels in rat pituitary melanotropes | Q72396400 | ||
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group | Q72759362 | ||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 5 | |
P304 | page(s) | 235-239 | |
P577 | publication date | 1997-07-01 | |
P1433 | published in | Brain Research | Q4955782 |
P1476 | title | G-proteins are involved in riluzole inhibition of high voltage-activated calcium channels in rat dorsal root ganglion neurons | |
P478 | volume | 762 |
Q44553308 | Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington's disease. |
Q43681745 | Effect of riluzole on the acquisition and expression of amygdala kindling |
Q37242602 | Riluzole in the treatment of mood and anxiety disorders |
Search more.